Form 4: Mirum Pharmaceuticals COO Peter Radovich Sells Shares
SEC Form 4 Filing
Peter Radovich, President and COO of Mirum Pharmaceuticals, sold 4,303 shares of common stock on March 25, 2024.
Summary
- On March 25, 2024, Peter Radovich, the President and COO of Mirum Pharmaceuticals, sold 4,303 shares of the company's common stock.
- The sale was executed at a weighted average price of $25.80 per share, with prices ranging from $25.80 to $25.825.
- Following the transaction, Radovich directly owns 29,013 shares of Mirum Pharmaceuticals.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission (SEC).
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by a company executive. It is neutral in tone and does not inherently convey positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies. They can be for personal financial planning or diversification. It is important to consider the context of the sale, such as the executive's overall holdings and the company's performance.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some investors, potentially leading to a slight decrease in stock price.
Key Dates
| Date | Description |
|---|---|
| 03/25/2024 | Date of stock sale transaction by Peter Radovich |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.